Ute Boon
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Microtubule and mitosis dynamics 3
- Oncology 4
- PARP inhibition in cancer therapy 4
- Co-authors
- Jos Jonkers (5 shared papers)Sven Rottenberg (2 shared papers)Rinske Drost (2 shared papers)Ellen Wientjens (2 shared papers)Niall M.B. Martin (1 shared paper)Janneke E. Jaspers (1 shared paper)Shridar Ganesan (1 shared paper)Liesbeth van Deemter (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Journal of Clinical Investigation (1 paper)British Journal of Cancer (1 paper)Cancer Discovery (1 paper)Cancer Cell (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Ute Boon
9 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 35
- Oncology 609
- Cancer Research 91
- Genetics 184
- Molecular Biology 327
- Cell Biology 66
Countries citing papers authored by Ute Boon
This map shows the geographic impact of Ute Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Boon more than expected).
Fields of papers citing papers by Ute Boon
This network shows the impact of papers produced by Ute Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Boon. The network helps show where Ute Boon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ute Boon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 439 | |
| 2 | 2011 | 224 | |
| 3 | 2016 | 183 | |
| 4 | 2016 | 118 | |
| 5 | 2015 | 99 | |
| 6 | 2022 | 86 | |
| 7 | 2018 | 35 | |
| 8 | 2015 | 1 | |
| 9 | 2016 | 1 |
About Ute Boon
Ute Boon is a scholar working on Cell Biology, Oncology, Genetics, Molecular Biology and Nuclear Energy and Engineering, having authored 9 papers that have together received 1.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), BRCA gene mutations in cancer (4 papers), Microtubule and mitosis dynamics (3 papers), PI3K/AKT/mTOR signaling in cancer (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Oncology (609 citations), Cancer Research (91 citations), Genetics (184 citations), Molecular Biology (327 citations) and Cell Biology (66 citations). Ute Boon has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jos Jonkers, Sven Rottenberg, Rinske Drost, Ellen Wientjens, Niall M.B. Martin, Janneke E. Jaspers, Shridar Ganesan, Liesbeth van Deemter, Alan Lau and Ariena J. Kersbergen. Their work appears in journals such as Annals of Oncology, Journal of Clinical Investigation, British Journal of Cancer, Cancer Discovery and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.